The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setterblad, N.
Right arrow Articles by Andersson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setterblad, N.
Right arrow Articles by Andersson, G.
The Journal of Immunology, 1998, 161: 4819-4824.
Copyright © 1998 by The American Association of Immunologists

The Role of Protein Kinase C Signaling in Activated DRA Transcription1

Niclas Setterblad2,*, Isaac Onyango{dagger}, Ulla Pihlgren*, Lars Rask{dagger} and Göran Andersson3,*

* Uppsala Genetic Center, Swedish University of Agricultural Sciences, and {dagger} Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden

Expression of human MHC HLA-DRA class II gene can be up-regulated in B cells by Ig cross-linking as well as by phorbol esters such as 12-O-tetradecanoyl phorbol 13-acetate (TPA). Induced DRA expression involves activation of restricted protein kinase C (PKC) isoforms, resulting in activated activator protein-1-dependent transcription. In this report expression profiles and activation of PKC were analyzed in human Raji B lymphoblastoid cells. Transient transfection analysis with target plasmids containing either DRA promoter (wild-type or mutated) or TPA response elements demonstrated that pretreatment with the selective PKC inhibitor GF 109203X repressed TPA-mediated activation. Western analysis performed on cellular fractions of resting cells and of TPA-activated cells revealed abundant expression of classical PKC-{alpha} (cPKC-{alpha}), cPKC-ßII, and atypical PKC-{zeta} isoforms and identified a sustained translocation of cPKC-{alpha} and cPKC-ßII from the cytosolic compartment to membranes. As expected, the distribution of atypical PKC-{zeta} was unaffected by TPA treatment and displayed an even distribution between cytosol and membranes. This finding was confirmed by immunofluorescence microscopy. The TPA-mediated translocation of cPKC-{alpha} and cPKC-ßII was not influenced by pretreatment with GF 109203X. Finally, functional activation and translocation of PKC were investigated with a selective in vitro kinase assay. Together, these results show that activated HLA-DRA expression in response to TPA treatment is strictly dependent on PKC activation acting on the X2 box of the DRA promoter and that selective inhibition of PKC enzymatic activity does not influence subcellular localization of expressed PKC isoenzymes. Thus, the translocation event per se occurs independently of PKC activation in these cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M.-J. Kwon, J.-W. Soh, and C.-H. Chang
Protein Kinase C{delta} Is Essential to Maintain CIITA Gene Expression in B Cells
J. Immunol., July 15, 2006; 177(2): 950 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. C. Clark, T. E. Dever, J. J. Dever, P. Xu, V. Rehder, M. A. Sosa, and D. J. Baro
Arthropod 5-HT2 Receptors: A Neurohormonal Receptor in Decapod Crustaceans That Displays Agonist Independent Activity Resulting from an Evolutionary Alteration to the DRY Motif
J. Neurosci., March 31, 2004; 24(13): 3421 - 3435.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Yokota, R. C. Ma, J.-Y. Park, K. Isshiki, K. B. Sotiropoulos, R. K. Rauniyar, K. E. Bornfeldt, and G. L. King
Role of Protein Kinase C on the Expression of Platelet-Derived Growth Factor and Endothelin-1 in the Retina of Diabetic Rats and Cultured Retinal Capillary Pericytes
Diabetes, March 1, 2003; 52(3): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Roucard, C. Thomas, M.-A. Pasquier, J. Trowsdale, J.-J. Sotto, J. Neefjes, and M. van Ham
In Vivo and In Vitro Modulation of HLA-DM and HLA-DO Is Induced by B Lymphocyte Activation
J. Immunol., December 15, 2001; 167(12): 6849 - 6858.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.